https://merztherapeutics.com/merz-therapeutics-submits-application-to-the-european-medicines-agency-for-new-indication-of-xeomin-in-pediatric-spasticity/
Merz Therapeutics Submits Application for New Indication of XEOMIN® in Pediatric Spasticity in...
Mar 31, 2026 - We’re taking specialty Neurology further. By expanding our reach and portfolio, we're striving to bring life-improving treatments to more people around the...
merz therapeuticsapplication forpediatric spasticitysubmitsnew